Skip to main content
. 2020 Sep 16;10:487. doi: 10.3389/fcimb.2020.00487

Figure 4.

Figure 4

Reduced expression of ABCF1 under VACV-70 stimulated conditions attenuates CXCL10 secretion. (A) Immunoblot confirming siRNA-mediated knockdown of ABCF1 protein expression in HBEC-6KT cells under experimental conditions of VACV-70 challenge. (B) Quantification of ABCF1 protein expression following siRNA treatment. (C) VACV-70 (3.16 μg/ml)-induced CXCL10 protein production for HBEC-6KT cells with ABCF1 siRNA treatment. Black bars: siCtrl treated. Gray bars: ABCF1 siRNA treated. (D) LDH quantification as a measure of cell viability following VACV-70 and siRNA treatment. (E) Phase-contrast microscopy (4X magnification) of HBEC-6KT following VACV-70 and siRNA treatment. All studies n = 3. *p < 0.05 and **p < 0.01.